The evidence base sits with the molecules, not the platforms STEP studied semaglutide for weight management (NEJM 2021), SURMOUNT studied tirzepatide (NEJM 2022), and SURMOUNT-OSA looked at tirzepatide in obstructive sleep apnea (NEJM 2024)
Muthukumaraswamy SD, Forsyth A, Lumley T Blinding and expectancy confounds in psychedelic randomized controlled trials
Accessed on August 29, 2023 at National Institute of Diabetes and Digestive and Kidney Diseases
adults seen as cost-secure fell from 61% in 2022 to 55% in 2023-24
The following topic directly reflected everyone's emotions regarding challenges in raising funds in the primary market, a significant decline in investment quantity, a severe shortage of departmental funds, and tightened project budgets, among other issues